Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05496855 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remote Care in People With Rheumatoid Arthritis

Study acronym: NOR-Flare
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 20, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2025 to Jun 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Lead sponsor: National Resource Center for Rehabilitation in Rheumatology to Diakonhjemmet Hospitalv2 Show 4 more changesShow less
    • Primary endpoint revised
    • Start date: Sep 1, 2022 to Sep 29, 2022
    • Study description expanded, about 126 words
    • Eligibility criteria expanded, about 5 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a 24-months, non-inferiority randomized, controlled trial with two parallel arms to determine if a new follow-up strategy for patients with RA is non-inferior in maintaining comprehensive disease control measured as simultaneous maintenance of structural, functional and clinical treatment target at 2-year follow-up compared to the conventional follow-up regimen with regular hospital visits.
Trial Details
NCT Number NCT05496855
Lead Sponsor Diakonhjemmet Hospital
Conditions
(from sponsor)		 Rheumatoid Arthritis
Related terms Arthritis, Rheumatoid
Enrollment 228 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov